Home › NDC Lookup › RxCUI directory › RxCUI 866419

24 HR metoprolol succinate 200 MG Extended Release Oral Tablet — RxCUI 866419

RxNorm drug concept · Semantic clinical drug
RxCUI 866419 Semantic clinical drug · SCD ● Current RxNorm concept 100 FDA products 255 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI866419
Official name24 HR metoprolol succinate 200 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmetoprolol succinate 200 MG 24HR Extended Release Oral Tablet; 24 HR metoprolol succinate 200 MG (as metoprolol succinate 190 MG equivalent to 200 MG metoprolol tartrate) Extended Release Oral Tablet
FDA products mapped100
Package NDCs mapped255
Reported Medicaid activity (SDUD)3,408,029 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Metoprolol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • That depends on why you were prescribed it. Metoprolol is a beta-blocker, which means it slows your heart rate and reduces the workload on your heart. Depending on your formulation...
  • What exactly is metoprolol supposed to do for me?
  • Please don't stop suddenly — this is one of the most important things to know about this drug. Stopping metoprolol abruptly, especially if you have any heart disease, can cause you...
  • Can I stop taking metoprolol if I feel fine or if it makes me tired?
📖 Read our full Metoprolol guide →

🕸️ Concept Web — How 24 HR metoprolol succinate 200 MG Extended Relea... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR metoprolol succinate 200 MG Extended Release Oral Tablet RxCUI 866419

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Metoprolol 6918
    • Metoprolol succinate 221124
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Toprol 865575
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Metoprolol Extended Release Oral Tablet 378660
    • Metoprolol succinate Extended Release Oral Tablet 2648648
    • Metoprolol Oral Product 1163523
    • Metoprolol Pill 1163524
    • Metoprolol succinate Oral Product 2659535
    • Metoprolol succinate Pill 2659117
    • Metoprolol Extended Release Oral Tablet [Toprol] 865577
    • Metoprolol succinate Extended Release Oral Tablet [Toprol] 2656065
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Metoprolol succinate 200 MG SCDC · 1370500
  • Metoprolol Extended Release Oral Tablet SCDF · 378660
  • Metoprolol succinate Extended Release Oral Tablet SCDFP · 2648648
  • Metoprolol Oral Product SCDG · 1163523
  • Metoprolol Pill SCDG · 1163524
  • Metoprolol succinate Oral Product SCDGP · 2659535
  • Metoprolol succinate Pill SCDGP · 2659117

Brand-Name Concepts

  • 24 HR metoprolol succinate 200 MG Extended Release Oral Tablet [Toprol] SBD · 866421
  • Metoprolol succinate 200 MG [Toprol] SBDC · 1370502
  • Metoprolol Extended Release Oral Tablet [Toprol] SBDF · 865577
  • Metoprolol succinate Extended Release Oral Tablet [Toprol] SBDFP · 2656065
  • Toprol Oral Product SBDG · 1178006
  • Toprol Pill SBDG · 1178007
  • Toprol BN · 865575

📦 FDA Products & Package NDCs

100 products · 255 package NDCs
255 package NDCs map to RxCUI 866419 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
75907-0345-10 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (7590... Metoprolol succinate Dr. Reddy's Laboratories Inc 2026-01-13
75907-0346-01 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (75907... Metoprolol succinate Dr. Reddy's Laboratories Inc 2026-01-13
75907-0346-05 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (75907... Metoprolol succinate Dr. Reddy's Laboratories Inc 2026-01-13
82009-0115-05 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (82009... Metoprolol succinate Quallent Pharmaceuticals Health LLC 2023-07-20
82009-0116-05 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (82009... Metoprolol succinate Quallent Pharmaceuticals Health LLC 2023-07-20
Observed labelers: BluePoint Laboratories (22) · Ascend Laboratories, LLC (20) · Ingenus Pharmaceuticals, LLC (20) · Camber Pharmaceuticals, Inc. (16) · Bryant Ranch Prepack (15) · Epic Pharma, LLC (12) · +20 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.